iShares Core US Aggregate Bond ETF vs Johnson & Johnson — how do they compare? iShares Core US Aggregate Bond ETF trades at $97.32, while Johnson & Johnson trades at $259 (market cap $626.09B). The key difference: Johnson & Johnson pays a 2.06% dividend while iShares Core US Aggregate Bond ETF pays none, and Johnson & Johnson is trading nearer its 52-week high, iShares Core US Aggregate Bond ETF nearer its low. Which is the better fit depends on your goals.
| AGG | JNJ | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $101.40 | $267.24 |
52-Week Low | $97.24 | $172.78 |
Market Cap | — | $626.09B |
Volume | — | 6,156,228 |
Enterprise Value | — | $654.37B |
Dividend Yield | — | 2.06% |
Trailing returns across standard periods
Latest headlines on both assets
AGG tracks the Bloomberg U.S. Aggregate Bond Index, providing broad exposure to the total U.S. investment-grade bond market. It serves as a core portfolio building block by diversifying across Treasuries, government-related bonds, corporate debt, and mortgage-backed securities.
Read more on AGG →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →